US news
fromwww.npr.org
9 hours agoMedicaid has a new way to pay for costly sickle cell treatment: Only if it works
A CMS-negotiated Medicaid payment model ties costly gene therapies for sickle cell to outcomes, requiring rebates if treatments fail and raising affordability concerns for Medicaid.